These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 9730714)

  • 1. Vitamin D3 withdrawal in hemodialysis patients with adynamic bone disease.
    Kondo M; Hyodo T; Sakai T
    Nephron; 1998 Sep; 80(1):89. PubMed ID: 9730714
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of depot oral cholecalciferol treatment on secondary hyperparathyroidism in stage 3 and stage 4 chronic kidney diseases patients.
    Dogan E; Erkoc R; Sayarlioglu H; Soyoral Y; Dulger H
    Ren Fail; 2008; 30(4):407-10. PubMed ID: 18569914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can a dietitian help prevent renal bone disease in the hemodialysis patient?
    Harum P
    Nephrol News Issues; 1990 Sep; 4(9):35, 37, 42. PubMed ID: 2402318
    [No Abstract]   [Full Text] [Related]  

  • 4. [Bone disease in patients with chronic renal failure and during long-term hemodialysis].
    Flury W
    Ther Umsch; 1972 Sep; 29(9):554-9. PubMed ID: 4628712
    [No Abstract]   [Full Text] [Related]  

  • 5. [Long-term treatment of secondary hyperparathyroidism in the chronic hemodialysis patient with 1,25-(OH)2D3].
    Giachino G; Giacchino F; Jeantet A; Del Piano A; Garetto A; Pellerey M; Piccoli G
    Minerva Med; 1985 Mar; 76(9-10):407-14. PubMed ID: 2984605
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment of chronic renal failure].
    Mimura N
    Nihon Naika Gakkai Zasshi; 1990 Sep; 79(9):1281-6. PubMed ID: 2175341
    [No Abstract]   [Full Text] [Related]  

  • 7. [The course of osteodystrophy in patients with chronic kidney failure on hemodialysis].
    Zemchenko AIu; Shostka GD
    Urol Nefrol (Mosk); 1993; (6):51-4. PubMed ID: 8160326
    [No Abstract]   [Full Text] [Related]  

  • 8. Osteopenia during long-term haemodialysis: response to vitamin D3 analogues.
    Muirhead N; Adami S; Fraser RA; Catto GR; Edward N; O'Riordan JL
    Proc Eur Dial Transplant Assoc; 1981; 18():567-72. PubMed ID: 6895786
    [No Abstract]   [Full Text] [Related]  

  • 9. Chronotherapy of high-dose active vitamin D3 in haemodialysis patients with secondary hyperparathyroidsm: a repeated dosing study.
    Tsuruoka S; Wakaumi M; Sugimoto K; Saito T; Fujimura A
    Br J Clin Pharmacol; 2003 Jun; 55(6):531-7. PubMed ID: 12814446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Renal osteodystrophy--more than a mere bone disease].
    Saha H
    Duodecim; 2001; 117(21):2181-7. PubMed ID: 12184205
    [No Abstract]   [Full Text] [Related]  

  • 11. [Skeletal changes in hemodialysis patients].
    Tantschew P; Tantschew I
    Beitr Orthop Traumatol; 1984 Jul; 31(7):344-50. PubMed ID: 6477464
    [No Abstract]   [Full Text] [Related]  

  • 12. Parathyroid disease in long-term maintenance hemodialysis.
    Pendras JP
    Arch Intern Med; 1969 Sep; 124(3):312-21. PubMed ID: 5806043
    [No Abstract]   [Full Text] [Related]  

  • 13. [Skeletal and soft part changes in patients on chronic dialysis].
    Herrmann K; Krohs G
    Z Gesamte Inn Med; 1974 Nov; 29(21):891-5. PubMed ID: 4462343
    [No Abstract]   [Full Text] [Related]  

  • 14. A daunting task but largely successful in developing meaningful guidelines.
    O'Neill WC
    Semin Dial; 2011; 24(1):24-7. PubMed ID: 21338388
    [No Abstract]   [Full Text] [Related]  

  • 15. Renal osteodystrophy during hemodialysis for chronic renal failure.
    Lirenman DS; Price JD; Lauener RW; Miller HS
    Can Med Assoc J; 1968 Oct; 99(13):668-74. PubMed ID: 5685514
    [No Abstract]   [Full Text] [Related]  

  • 16. Mineral metabolism and renal bone disease: effects of CAPD versus hemodialysis.
    Coburn JW
    Kidney Int Suppl; 1993 Feb; 40():S92-100. PubMed ID: 8445845
    [No Abstract]   [Full Text] [Related]  

  • 17. Can renal bone disease be prevented?
    Shaldon S
    Proc Eur Dial Transplant Assoc; 1973; 10(0):91-123. PubMed ID: 4808119
    [No Abstract]   [Full Text] [Related]  

  • 18. Off-label use of phosphate binders in non-dialysis-dependent CKD.
    Winkelmayer WC; Chertow GM
    Am J Kidney Dis; 2010 Nov; 56(5):813-6. PubMed ID: 20970022
    [No Abstract]   [Full Text] [Related]  

  • 19. [Calcitonin for therapy of renal osteodystrophy due to long-term hemodialysis in patients with chronic kidney failure].
    Ishida M; Yamada M
    Nihon Rinsho; 1991 Dec; 49 Suppl():725-31. PubMed ID: 1808343
    [No Abstract]   [Full Text] [Related]  

  • 20. [Vascular and tissue calcifications of hemodialysis patients].
    Peñalba A; Neme G; Tirado S
    Nefrologia; 2003; 23 Suppl 2():112-6. PubMed ID: 12778866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.